Previous Close | 19.34 |
Open | 19.61 |
Bid | 14.51 x 800 |
Ask | 25.50 x 800 |
Day's Range | 19.51 - 20.05 |
52 Week Range | 14.94 - 50.40 |
Volume | |
Avg. Volume | 300,496 |
Market Cap | 517.166M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.66 |
Earnings Date | Aug 10, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for ZIMV
Third party net sales of $233.4 millionNet loss of ($8.7) million; net loss margin of (3.7%); adjusted net income[1] of $17.6 million Diluted EPS of ($0.33); adjusted diluted EPS[1] of $0.67Adjusted EBITDA[1] of $31.3 million; adjusted EBITDA margin[1] of 13.4% Cash and cash equivalents of $130.1 million at June 30, 2022, up from $104.3 million at March 31, 2022 WESTMINSTER, Colo., Aug. 10, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine
We feel now is a pretty good time to analyse ZimVie Inc.'s ( NASDAQ:ZIMV ) business as it appears the company may be on...
WESTMINSTER, Colo., July 20, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 10, 2022. Company management will host a corresponding audio webcast beginning at 4:30 p.m. Eastern Time. Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minut